20 Results

People

  1. Brentjens
    Brentjens
  2. Sadelain
    Sadelain
  3. Curran
    Curran
  4. Pegram
    Pegram
  5. Purdon
    Purdon
  6. Riviere
    Riviere
  7. van Leeuwen
    van Leeuwen
  8. Daniyan
    Daniyan
  9. Heller
    Heller
  10. Larson
    Larson

Groups

  1. Adult Leukemia (20)
  2. Center for Hematologic Malignancies (20)
  3. Department of Medicine (20)
  4. GSK Faculty (20)
  5. Hematologic Malignancies Research (20)
  6. Hematologic Malignancies, Division of (20)
  7. Molecular Pharmacology and Chemistry Program Faculty (8)
  8. Sloan Kettering Institute Faculty (8)
  9. Pediatrics, Department of (6)
  10. Sloan Kettering Institute Postdocs (6)
  1. "adoptive transfer"
  2. "Hematologic Malignancies Research"
  3. "GSK Faculty"
  4. "Adult Leukemia"
Formats
  1. Journal Article (20)
Groups
  1. Adult Leukemia (20)
  2. Center for Hematologic Malignancies (20)
  3. Department of Medicine (20)
  4. GSK Faculty (20)
  5. Hematologic Malignancies Research (20)
  6. Hematologic Malignancies, Division of (20)

More Groups

People
  1. Renier Brentjens (18)
  2. Michel Sadelain (6)
  3. Kevin Curran (4)
  4. Dayenne van Leeuwen (3)
  5. Hollie Pegram (3)
  6. Isabelle Riviere (3)

More People

Years
  1. 2023 (1)
  2. 2019 (1)
  3. 2018 (1)
  4. 2015 (3)
  5. 2013 (3)
  6. 2012 (2)

More Years

Publications
  1. Hematology/Oncology Clinics of North America (2)
  2. Nature Medicine (2)
  3. Biochemical and Biophysical Research Communications (1)
  4. Cancer Cell (1)
  5. Cancer Research (1)
  6. Cell Reports (1)

More Publications

Publishers
  1. Nature Publishing Group (4)
  2. American Association for Cancer Research (2)
  3. Cell Press (2)
  4. Elsevier Inc. (2)
  5. Lippincott Williams & Wilkins (2)
  6. Academic Press Inc., Elsevier Science (1)

More Publishers

Results (20)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Engineering CAR-T cells for radiohapten capture in imaging and radioimmunotherapy applications
    Journal Article

    Kurtz, K.; Eibler, L.; Dacek, M. M.; Carter, L. M.; Veach, D. R.; Lovibond, S.; Reynaud, E.; Qureshy, S.; McDevitt, M. R.; Bourne, C.; more...
    Theranostics (2023)

    Fulltext@MSK | Save
  • CD40 ligand-modified chimeric antigen receptor T cells enhance antitumor function by eliciting an endogenous antitumor response
    Journal Article

    Kuhn, N. F.; Purdon, T. J.; van Leeuwen, D. G.; Lopez, A. V.; Curran, K. J.; Daniyan, A. F.; Brentjens, R. J.
    Cancer Cell (2019)

    Fulltext@MSK | Save
  • Engineered tumor-targeted T cells mediate enhanced anti-tumor efficacy both directly and through activation of the endogenous immune system
    Journal Article

    Avanzi, M. P.; Yeku, O.; Li, X.; Wijewarnasuriya, D. P.; van Leeuwen, D. G.; Cheung, K.; Park, H.; Purdon, T. J.; Daniyan, A. F.; Spitzer, M. H.; more...
    Cell Reports (2018)

    Fulltext@MSK | Save
  • CD19-targeted t cells for hematologic malignancies clinical experience to date
    Journal Article

    Davila, M. L.; Sauter, C.; Brentjens, R.
    The Cancer Journal (2015)

    Fulltext@MSK | Save
  • A phase I clinical trial of adoptive T cell therapy using IL-12 secreting MUC-16ecto directed chimeric antigen receptors for recurrent ovarian cancer
    Journal Article

    Koneru, M.; O'cearbhaill, R.; Pendharkar, S.; Spriggs, D. R.; Brentjens, R. J.
    Journal of Translational Medicine (2015)

    Fulltext@MSK | Save
  • IL-12-secreting CD19-targeted cord blood-derived T cells for the immunotherapy of B-cell acute lymphoblastic leukemia
    Journal Article

    Pegram, H. J.; Purdon, T. J.; van Leeuwen, D. G.; Curran, K. J.; Giralt, S. A.; Barker, J. N.; Brentjens, R. J.
    Leukemia (2015)

    Fulltext@MSK | Save
  • CD19 target-engineered T-cells accumulate at tumor lesions in human B-cell lymphoma xenograft mouse models
    Journal Article

    Tsukahara, T.; Ohmine, K.; Yamamoto, C.; Uchibori, R.; Ido, H.; Teruya, T.; Urabe, M.; Mizukami, H.; Kume, A.; Nakamura, M.; more...
    Biochemical and Biophysical Research Communications (2013)

    Fulltext@MSK | Save
  • Engineered human embryonic stem cell-derived lymphocytes to study in vivo trafficking and immunotherapy
    Journal Article

    Knorr, D. A.; Bock, A.; Brentjens, R. J.; Kaufman, D. S.
    Stem Cells and Development (2013)

    Fulltext@MSK | Save
  • Chimeric Antigen Receptor Therapy for Chronic Lymphocytic Leukemia. What are the Challenges?
    Journal Article

    Davila, M. L.; Brentjens, R.
    Hematology/Oncology Clinics of North America (2013)

    Fulltext@MSK | Save
  • Novel cellular therapies for leukemia: CAR-modified T cells targeted to the CD19 antigen
    Journal Article

    Brentjens, R. J.; Curran, K. J.
    Hematology-American Society of Hematology Education Program (2012)

    Fulltext@MSK | Save